CLASS II Drug recall · Reported 3 Aug 2022 · FDA Enforcement Report

Testosterone Gel 1% (25mg testosterone/ of gel) per unit dose recalled

Teva Pharmaceuticals USA is recalling Testosterone Gel 1% (25mg testosterone/ of gel) per unit dose, distributed nationwide in the US. The recall was initiated on 29 Jun 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 1403180, EXP. 10/2022
NDC0591-2921, 0591-3216, 0591-3217
Quantity recalled12354 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1289-2022
FDA event ID
90534
Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Manufacturer
Actavis Pharma, Inc.
Classification
Class II
Status
Terminated
Recall initiated
29 Jun 2022
FDA classified
25 Jul 2022
Reported
3 Aug 2022
Type
Voluntary: Firm initiated
Reason category
Potency & Assay

Timeline

29 Jun 2022Recall initiated by company
25 Jul 2022Classified by FDA+26 days
3 Aug 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Superpotent Drug: Out of specification assay result was obtained during stability testing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, US 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, Sachet NDC 0591-3216-17, Carton NDC 0591-3216-30

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Superpotent Drug: Out of specification assay result was obtained during stability testing.

Which lots are affected?

Lot: 1403180, EXP. 10/2022

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 281

Other Testosterone recalls

All 91